Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Prashanth Lingamaneni
Observed name:
P. Lingamaneni
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5013144673
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial
2025
·
Jacob J. Orme
, Henan Zhang
, et al.
·
Nature Communications
·
8
1518MO Rescuing cancer immunotherapy with plasma exchange in melanoma (the ReCIPE-M1 study)
2025
·
J. Orme
, H. Zhang
, et al.
·
Annals of Oncology
Rescuing Cancer Immunotherapy with Radiation & Plasma Exchange in Melanoma
2024
·
Jacob Orme
, Henan Zhang
, et al.
·
SSRN Electronic Journal
50P Patient-reported outcomes in non-small cell lung cancer patients receiving immunotherapy monotherapy: Analysis from enhanced, EHR-facilitated cancer symptom control (E2C2) pragmatic clinical trial
2023
·
B. Liu
, V. Lam
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
4
Citation count:
8
H-index:
1
I10-index:
Year
Topic
Type
